Navigation Links
Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month
Date:10/19/2007

Neurologic and Orthopedic Institute of Chicago Offer Complimentary Brain

Scans, Oct 26 & 27, as Part of Clinical Study.

CHICAGO, Oct. 19 /PRNewswire/ --

What: Women diagnosed with HER-2 positive Stage III or Stage IV

breast cancer are eligible to receive an MRI of the brain

at no charge as part of a clinical trial. HER2 is a breast

cancer that tests positive for a protein called human

epidermal growth factor receptor-2 (HER2), which promotes

the growth of cancer cells. Studies have shown that in as

many as 30 percent of breast cancer patients have a

metastasis in the brain. As part of the screening

protocol, participants will undergo a MRI of the brain. The

cost of the MRI is covered by the clinical trial.

Who: Patients who qualify must have an initial primary diagnosis

of high risk and/or HER-2 positive breast cancer. They

must be at least 18 years and should not participate if

they are pregnant.

When: Friday, October 26th, 1 p.m. to 9 p.m.

Saturday, October 27th, 8 a.m. to 5 p.m.

Where: Neurologic and Orthopedic Institute of Chicago

4501 N. Winchester, Chicago

Cost: The brain MRI is free of charge to the patient.

Background: The Chicago Institute of Neurosurgery and Neuroresearch

(CINN) Medical Group will use information from the

screening to determine the potentialbenefit(s) of screening

for brain metastases in patients with advanced breast

cancer.

Study Selection & Enrollment Criteria

Women must be within three to twenty-four months of first

metastases of Stage IV diagnosis or within 12 to 24 months

of initial diagnosis of HER-2 positive Stage III disease.

They must sign a written consent form approved by the CINN

Institutional Review Board (IRB).

Exclusion criteria

Patients with a prior diagnosis of brain metastases or who

are unable to be safely exposed to MRIs. Most common

exclusions include, but are not limited to, pacemakers,

implanted defibrillators, neurostimulators, aneurysm clips,

cochlear devices, or any other institution

contraindications. Women who are pregnant.

CONTACT: Sandi Davis of Chicago Institute of Neurosurgery and Neuroresearch, 773-250-0425, http://www.cinn.org

Media Contact: Lisa Stafford, P.S. Communications, 630-986-8749, Cell: 630-212-1226, Email: lisa@pscommunicationsinc.com


'/>"/>
SOURCE Chicago Institute of Neurosurgery and Neuroresearch
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
4. “Brain fingerprinting”- The new lie detectr
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Two doctors suspended for wrong brain surgery
7. The brain loves a surprise
8. Virus Combats Brain Tumour
9. Increase in sugar...decrease in brain function!!!
10. Alcohol shrinks brain
11. Roller coaster takes brain for a big ride!!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: